Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Prediction and clinical utility of a contralateral breast cancer risk model

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Sensitivity of screening mammography by density and texture: a cohort study from a population-based screening program in Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Long-term exposure to road traffic noise and incidence of breast cancer: a cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Genetic variation at PPP1R3B increases hepatic CT attenuation and interacts with prandial status on plasma glucose

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Tocilizumab and soluble interleukin-6 receptor in JAK2V617F somatic mutation and myeloproliferative neoplasm

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Transcriptome-wide association study reveals candidate causal genes for lung cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. Impact of Glucose Level on Micro- and Macrovascular Disease in the General Population: A Mendelian Randomization Study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Taru A Muranen
  • Carl Blomqvist
  • Thilo Dörk
  • Anna Jakubowska
  • Päivi Heikkilä
  • Rainer Fagerholm
  • Dario Greco
  • Kristiina Aittomäki
  • Stig E Bojesen
  • Mitul Shah
  • Alison M Dunning
  • Valerie Rhenius
  • Per Hall
  • Kamila Czene
  • Judith S Brand
  • Hatef Darabi
  • Jenny Chang-Claude
  • Anja Rudolph
  • Børge G Nordestgaard
  • Fergus J Couch
  • Steven N Hart
  • Jonine Figueroa
  • Montserrat García-Closas
  • Peter A Fasching
  • Matthias W Beckmann
  • Jingmei Li
  • Jianjun Liu
  • Irene L Andrulis
  • Robert Winqvist
  • Katri Pylkäs
  • Arto Mannermaa
  • Vesa Kataja
  • Annika Lindblom
  • Sara Margolin
  • Jan Lubinski
  • Natalia Dubrowinskaja
  • Manjeet K Bolla
  • Joe Dennis
  • Kyriaki Michailidou
  • Qin Wang
  • Douglas F Easton
  • Paul D P Pharoah
  • Marjanka K Schmidt
  • Heli Nevanlinna
Vis graf over relationer

BACKGROUND: P.I157T is a CHEK2 missense mutation associated with a modest increase in breast cancer risk. Previously, another CHEK2 mutation, the protein truncating c.1100delC has been associated with poor prognosis of breast cancer patients. Here, we have investigated patient survival and characteristics of breast tumors of germ line p.I157T carriers.

METHODS: We included in the analyses 26,801 European female breast cancer patients from 15 studies participating in the Breast Cancer Association Consortium. We analyzed the association between p.I157T and the clinico-pathological breast cancer characteristics by comparing the p.I157T carrier tumors to non-carrier and c.1100delC carrier tumors. Similarly, we investigated the p.I157T associated risk of early death, breast cancer-associated death, distant metastasis, locoregional relapse and second breast cancer using Cox proportional hazards models. Additionally, we explored the p.I157T-associated genomic gene expression profile using data from breast tumors of 183 Finnish female breast cancer patients (ten p.I157T carriers) (GEO: GSE24450). Differential gene expression analysis was performed using a moderated t test. Functional enrichment was investigated using the DAVID functional annotation tool and gene set enrichment analysis (GSEA). The tumors were classified into molecular subtypes according to the St Gallen 2013 criteria and the PAM50 gene expression signature.

RESULTS: P.I157T was not associated with increased risk of early death, breast cancer-associated death or distant metastasis relapse, and there was a significant difference in prognosis associated with the two CHEK2 mutations, p.I157T and c.1100delC. Furthermore, p.I157T was associated with lobular histological type and clinico-pathological markers of good prognosis, such as ER and PR expression, low TP53 expression and low grade. Gene expression analysis suggested luminal A to be the most common subtype for p.I157T carriers and CDH1 (cadherin 1) target genes to be significantly enriched among genes, whose expression differed between p.I157T and non-carrier tumors.

CONCLUSIONS: Our analyses suggest that there are fundamental differences in breast tumors of CHEK2:p.I157T and c.1100delC carriers. The poor prognosis associated with c.1100delC cannot be generalized to other CHEK2 mutations.

OriginalsprogEngelsk
TidsskriftBreast Cancer Research
Vol/bind18
Udgave nummer1
Sider (fra-til)98
ISSN1465-542X
DOI
StatusUdgivet - 3 okt. 2016

ID: 49370976